Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN16377955
ISRCTN16377955
Active, not recruiting
未知

Curbing High Risk of Non-obstructive smokers

niversity Hospital of Basel0 sites158 target enrollmentAugust 18, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsChronic Obstructive Pulmonary Disease GOLD 0 is defined as patients with normal spirometry but with chronic symptoms such as cough and/or sputum production.Respiratory

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease GOLD 0 is defined as patients with normal spirometry but with chronic symptoms such as cough and/or sputum production.
Sponsor
niversity Hospital of Basel
Enrollment
158
Status
Active, not recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 18, 2022
End Date
December 31, 2023
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity Hospital of Basel

Eligibility Criteria

Inclusion Criteria

  • •Both groups:
  • •1\. Able to give informed consent as documented by signature
  • •2\. Age \=40 years
  • •3\. FEV1/FVC \=0\.70
  • •Intervention group: Current or past smokers
  • •4\. \=10 pack years
  • •5\. At least one symptom from the following: (Cough, Phlegm, Shortness of breath)
  • •Control group: Minimal smoking exposure
  • •6\. \=1 pack year tobacco\-smoking history

Exclusion Criteria

  • •Both groups:
  • •1\. Pregnant or lactating women
  • •2\. Current increased (more than usual) respiratory symptoms
  • •3\. Concomitant respiratory disease (eg asthma, ILD) or clinically significant bronchiectasis
  • •4\. Unstable cardiovascular disease
  • •5\. Inability to follow the procedures of the study, e.g. due to language problems, dementia, etc.
  • •6\. Active pulmonary infection or prior pulmonary infection where antibiotic and/or steroid treatment was completed \=4 weeks prior to enrolment
  • •7\. Enrolment in an interventional clinical trial within last 30 days
  • •8\. Severe immunosuppression including manifested AIDS, organ transplantation, ongoing chemotherapy for cancer or neutropenia (\<500\*10^9/L)
  • •9\. Chronic use of oral steroids (\>10 mg per day)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Prevention of nicotine-associated morbidity by smoking cessation counselling in trauma patients in an emergency department
ISRCTN41527831Charité - University Medicine Berlin (Charité - Universitätsmedizin Berlin) (Germany)1,044
Completed
Not Applicable
Reduction of Secondhand Smoke Exposure in Healthy InfantsEffect of intervention on smoker parents on home, car and outside of home and car smoking bans status and Infant's urinary cotinine levels.Passive smoking
IRCT138801171791N1Tehran University of Medical Sciences and Health Services130
Active, not recruiting
Phase 1
Prevention of nicotine abstinence symptoms in critically ill patientsicotin abstinence deliriumTherapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2014-003720-43-CZFakultní nemocnice Ostrava100
Completed
Not Applicable
Increasing the prevalence of functioning smoke alarms in disadvantaged inner city housing: a randomised controlled trialPublic health, social medicineNot ApplicablePublic health
ISRCTN47572799Medical Research Council (MRC) (UK)1,440
Completed
Not Applicable
A brief intervention to prevent smoking relapse in cardiac patients: a randomised controlled trialCardiovascular diseases: Heart diseaseCirculatory SystemHeart disease
ISRCTN13036545Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)540